Beximco sales up 28% on all-round growth
This article was originally published in Scrip
Executive Summary
Beximco Pharmaceuticals of Bangladesh has reported a 28% increase in net sales to Bangladesh Taka (BDT) 2,969 million (£27.3 million) for the six months ended 30 June, buoyed by all-round growth. Profit before tax increased by 83% to BDT697.3 million (£6.4 million).